Ballsy Celgene Continues to Tread Carefully Into Neurosciences Post author:Sam Post published:January 25, 2018 Post category:BioPharma The company made some bold moves this month in acquiring Juno and Impact Source: BioSpace You Might Also Like Meet the Scientist Finding Success at Other Biotechs Working on Old Pfizer Compounds June 12, 2017 AstraZeneca Canada Release: Pan-Canadian Oncology Drug Review Recommendation Supports The Use Of Tagrisso (Osimertinib) As The Standard Of Care For T790M Mutated Non-Small Cell Lung Cancer May 7, 2017 <b>MaxWell Biosciences</b> CEO Faces Backlash After Openly Discriminating Against Men September 26, 2017
AstraZeneca Canada Release: Pan-Canadian Oncology Drug Review Recommendation Supports The Use Of Tagrisso (Osimertinib) As The Standard Of Care For T790M Mutated Non-Small Cell Lung Cancer May 7, 2017
<b>MaxWell Biosciences</b> CEO Faces Backlash After Openly Discriminating Against Men September 26, 2017
